Evidence map›Paper›PMID 30056832›Full record

ArticleNeuron2018

Triheteromeric GluN1/GluN2A/GluN2C NMDARs with Unique Single-Channel Properties Are the Dominant Receptor Population in Cerebellar Granule Cells.

Subhrajit Bhattacharya, Alpa Khatri, Sharon A Swanger, John O DiRaddo, Feng Yi, Kasper B Hansen, Hongjie Yuan, Stephen F Traynelis

Open access · bronzeAbstract read
In one paragraph

Article in Neuron, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 73 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Structural prediction of GluN3 NMDA receptors.Frontiers in physiology · 2024
    Article
  18. Therapeutic potential of N-methyl-D-aspartate receptor modulators in psychiatry.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
    Review
  19. Article
  20. Selective Cell-Surface Expression of Triheteromeric NMDA Receptors.Methods in molecular biology (Clifton, N.J.) · 2024
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Subhrajit BhattacharyaDepartment of Pharmacology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Alpa KhatriDepartment of Pharmacology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Sharon A SwangerDepartment of Pharmacology, Emory University School of Medicine, Atlanta, GA 30322, USA.
John O DiRaddoDepartment of Pharmacology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Feng YiDepartment of Biomedical and Pharmaceutical Sciences, University of Montana, Missoula, MT 59812, USA.
Kasper B HansenDepartment of Biomedical and Pharmaceutical Sciences, University of Montana, Missoula, MT 59812, USA.
Hongjie YuanDepartment of Pharmacology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Stephen F TraynelisDepartment of Pharmacology, Emory University School of Medicine, Atlanta, GA 30322, USA. Electronic address: strayne@emory.edu.
Emory University · USUniversity of Montana · US

Funding

Surveillance genome sequencing to detect SARS-CoV-2 virus variants in MontanaP20GM103546 · NIGMS · UNIVERSITY OF MONTANA · PI BOWLER, BRUCE E · 2012 to 2021
$19.2M
Control of Glutamate Receptor FunctionR01NS036654 · NINDS · EMORY UNIVERSITY · PI TRAYNELIS, STEPHEN F · 1998 to 2018
$3.7M
Mechanism of Action of Novel Subunit-Selective NMDA Receptor ModulatorsR01NS065371 · NINDS · EMORY UNIVERSITY · PI TRAYNELIS, STEPHEN F · 2009 to 2018
$3.4M
Structural and functional investigation of negative allosteric NMDA receptor modulationR01NS097536 · NINDS · UNIVERSITY OF MONTANA · PI Kasper Boe Hansen · 2016 to 2026
$3.4M
NMDAR Mutations & Neurodevelopmental Disorder: from Mechanism to Targeted TherapyR01HD082373 · NICHD · EMORY UNIVERSITY · PI YUAN, HONGJIE · 2015 to 2025
$3.3M
Control of glutamate receptor functionR37NS036654 · NINDS · EMORY UNIVERSITY · PI TRAYNELIS, STEPHEN F · 2007 to 2013
$2.4M
Mechanism of action of novel GluN2C NMDA receptor potentiatorsF32NS078873 · NINDS · EMORY UNIVERSITY · PI KHATRI, ALPA · 2012 to 2013
$106k
NICHD NIH HHS R01 HD082373NIGMS NIH HHS P20 GM103546NINDS NIH HHS F32 NS078873NINDS NIH HHS R01 NS036654NINDS NIH HHS R01 NS065371NINDS NIH HHS R01 NS097536NINDS NIH HHS R37 NS036654
6 · The paper itself

Abstract

NMDA-type glutamate receptors (NMDARs) are ligand-gated ion channels that mediate excitatory neurotransmission in the CNS. Here we describe functional and single-channel properties of triheteromeric GluN1/GluN2A/GluN2C receptors, which contain two GluN1, one GluN2A, and one GluN2C subunits. This NMDAR has three conductance levels and opens in bursts similar to GluN1/GluN2A receptors but with a single-channel open time and open probability reminiscent of GluN1/GluN2C receptors. The deactivation time course of GluN1/GluN2A/GluN2C receptors is intermediate to GluN1/GluN2A and GluN1/GluN2C receptors and is not dominated by GluN2A or GluN2C. We show that triheteromeric GluN1/GluN2A/GluN2C receptors are the predominant NMDARs in cerebellar granule cells and propose that co-expression of GluN2A and GluN2C in cerebellar granule cells occludes cell surface expression of diheteromeric GluN1/GluN2C receptors. This new insight into neuronal GluN1/GluN2A/GluN2C receptors highlights the complexity of NMDAR signaling in the CNS.

Indexed as

AnimalsCerebellumDose-Response Relationship, DrugExcitatory Amino Acid AgonistsFemaleHEK293 CellsHumansMaleMiceMice, Inbred C57BLMice, KnockoutNerve Tissue ProteinsOrgan Culture TechniquesRatsRats, Sprague-DawleyReceptors, N-Methyl-D-AspartateExcitatory Amino Acid AgonistsGprin1 protein, mouseNerve Tissue ProteinsNR2C NMDA receptorReceptors, N-Methyl-D-Aspartatecerebellar granule cellsexcitatory neurotransmissionionotropic glutamate receptorsligand-gated ion channel

Identifiers

PMID30056832
PMCPMC6090556
OpenAlexW2811141452

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.